OncoLink at ASTRO 2001: Wednesday, November 7

Check back for ASTRO 2001 coverage for Wednesday, November 7^th.

OncoLink Team at ASTRO 2001. Booth 2450.

Brain Metastases in Lung Cancer: The Results of Radiosurgery in 238 Consecutive Patients Presenter: B.E. Amendola Presenter's Affiliation: Radiosurgery Department, Miami Neuroscience Center, Coral Gables, FL Type of Session: Scientific Background Lung cancer is the leading cause of cancer death in this country. 50% of all brain...
Concurrent Chemoradiation for Locally Advanced NSCLC in the RTOG Experience: Effect of Overall Treatment Time Presenter: M. Machtay Presenter's Affiliation: University of Pennsylvania Type of Session: Scientific Background A survival advantage has been shown in patients with non small cell lung cancer (NSCLC) with concurrent chemoradiation vs sequential...
Improved Local Control with RSR-13 and Concurrent Radiation Therapy in a Phase II Study for Locally Advanced Inoperable Non-Small Cell Lung Cancer Presenter: H. Choy Presenter's Affiliation: Vanderbilt University Medical Center, Nashville, TN Type of Session: Scientific Background RSR13 is a synthetic allosteric modifier of hemeglobin (Hb). It decreases Hb-oxygen binding affinity by causing a...
Neoadjuvant Chemotherapy and Radiotherapy for Large Extremity Soft Tissue Sarcomas Presenter: T.F. DeLaney Presenter's Affiliation: Massachusetts General Hospital, Boston, MA Type of Session: Scientific Background The management of extremity soft tissue sarcomas has evolved from amputation to limb sparing surgery with radiation...
Preliminary Report of Toxicity Following 3D Conformal Radiation Therapy (3DCRT) for Prostate Cancer on 3DOG/RTOG 9406, Level III (79.2 Gy) Presenter: J. Ryu Presenter's Affiliation: Rad Onc, UCD, Sacramento, CA Type of Session: Scientific Background The high rates of local relapse observed in prostate cancer patients with conventional radiation techniques have stimulated research to...
Presentation, Prognostic Factors and Patterns of Failure in Adult Rhabdomyosarcoma Presenter: J.H. Simon Presenter's Affiliation: University of Iowa, Iowa City Type of Session: Scientific Background Rhabdomyosarcoma is the most common soft tissue sarcoma of childhood, with about 400 new cases per year. Five year survival rates are...
Results of Whole Brain Radiation Therapy in Breast Cancer Patients with Brain Metastases Presenter: A.S. Mahmoud-ahmed Presenter's Affiliation: Radiation Oncology, Cleveland Clinic Foundation, Cleveland, OH Type of Session: Scientific Background Brain metastasis is the most common neurologic complication experienced breast cancer...
Sexual Function after Permanent Prostate Brachytherapy Presenter: W.M. Butler Presenter's Affiliation: Schiffler Cancer Center, Wheeling Hospital, Wheeling Type of Session: Scientific Background There continues to be uncertainty about the incidence of impotence after radiation therapy for prostate...
Sildenafil (Viagra) and Erectile Dysfunction following Conformal Radiotherapy for Prostate Cancer: A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study Presenter: L. Incrocci Presenter's Affiliation: University Hospital Rotterdam-Daniel Type of Session: Scientific Background The incidence of Erectile Dysfunction (ED) following external beam radiation therapy is commonly reported as 35-45%. With...
Stereotactic Radiosurgery (SRS) Dose Selection for < 2 cm Brain Metastases: The Influence of Planned Whole Brain Radiation Therapy (WBRT) Presenter: Young, AB Presenter's Affiliation: Neurosurgery, University of Kentucky, Lexington, KY Type of Session: Scientific Background Based on RTOG 9005, 24 Gy as SRS dose for treatment of brain metastases This analysis reviews a single...
Treatment of Prostate Cancer with Radiotherapy: Should the Entire Seminal Vesicles be Included in the CTV Presenter: L.L. Kestin Presenter's Affiliation: William Beaumont Hospital Type of Session: Scientific Background Dose escalation (to upper 70s to >80 Gy) has been shown to be efficacious in the treatment of prostate cancer. With this...
Treatment, Patient and Tumor Characteristics Impact Quality of Life (QOL) in Patients with Locally Advanced Head and Neck Cancer: Report of the Radiation Therapy Oncology Group (RTOG) Trial 90-03 Presenter: J. Fisher Presenter's Affiliation: Bon Secours Cottage Health Services, Grosse Pointe Farms, MI Type of Session: Scientific Background The RTOG 90-03 was a four-arm trial that enrolled patients with locally advanced head and neck cancer....